Townsend Richard Nolan
SEC CIK 1995218 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | CEO, Dir | 374.5K | — | $1.96M | 35 | 2024-01-05 | 2026-08-18 |
Most active insiders at LXEO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Townsend Richard Nolan | CEO, Dir | — | $655.7K |
| 2 | Bhalla Narinder Pal | Chief Medical Off | — | $98.6K |
| 3 | Otero Jose Manuel | Chief Technical Off | — | $78.9K |
| 4 | Tamayo Louis Edward | CFO | — | $41.0K |
| 5 | See Tai Sandi | Chief Development Off | — | $38.4K |
| 6 | Robertson Jenny | CLO | — | $36.6K |
| 7 | Adler Eric | Chief Medical Off | — | $36.0K |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 17:00 | 2026-08-18 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.95 | -3,345 | 374.5K | -0.9% | -$16.6K | |
| 2026-07-01 18:47 | 2026-06-29 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +67.0K | 403.8K | +20% | $0 | |
| 2026-07-01 18:47 | 2026-07-01 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.48 | -25.9K | 377.8K | -6% | -$116.2K | |
| 2026-05-20 16:30 | 2026-05-18 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $5.06 | -3,342 | 336.8K | -1.0% | -$16.9K | |
| T | 2026-04-07 16:55 | 2026-04-06 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $5.69 | -55.0K | 340.1K | -14% | -$313.1K |
| 2026-03-17 | 2026-03-13 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | A - Grant | $2.64 | +2,623 | 395.1K | +0.7% | +$6,925 | |
| 2026-02-20 | 2026-02-18 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $6.38 | -10.2K | 392.5K | -3% | -$64.9K | |
| D | 2026-02-06 | 2026-02-04 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +161.7K | 402.7K | +67% | $0 |
| 2025-11-20 | 2025-11-18 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $9.27 | -1,127 | 241.0K | -0.5% | -$10.4K | |
| 2025-10-17 | 2025-10-15 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +33.0K | 255.3K | +15% | $0 | |
| M | 2025-10-17 | 2025-10-17 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $8.95 | -13.1K | 242.1K | -5% | -$117.5K |
| 2025-09-16 | 2025-09-12 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | A - Grant | $2.64 | +2,193 | 222.3K | +1.0% | +$5,790 | |
| A | 2025-09-10 | 2025-08-18 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.67 | -1,115 | 220.1K | -0.5% | -$5,207 |
| 2025-08-20 | 2025-08-18 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.67 | -2,735 | 220.1K | -1% | -$12.8K | |
| 2025-05-20 | 2025-05-16 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $2.77 | -1,074 | 221.2K | -0.5% | -$2,975 | |
| 2025-04-01 | 2025-03-14 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | A - Grant | $2.61 | +2,128 | 222.2K | +1.0% | +$5,554 | |
| 2025-02-21 | 2025-02-19 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.41 | -4,326 | 220.1K | -2% | -$19.1K | |
| D | 2025-01-10 | 2025-01-07 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +103.8K | 224.4K | +86% | $0 |
| D | 2024-12-12 | 2024-12-10 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +2,500 | 123.2K | +2% | +$5,825 |
| D | 2024-12-12 | 2024-12-10 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $8.20 | -2,500 | 120.7K | -2% | -$20.5K |
| D | 2024-11-13 | 2024-11-11 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $7.82 | -2,500 | 120.7K | -2% | -$19.6K |
| D | 2024-11-13 | 2024-11-11 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +2,500 | 123.2K | +2% | +$5,825 |
| D | 2024-10-15 | 2024-10-10 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 125.7K | +4% | +$11.7K |
| D | 2024-10-15 | 2024-10-10 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $8.10 | -5,000 | 120.7K | -4% | -$40.5K |
| D | 2024-09-11 | 2024-09-10 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $10.65 | -5,000 | 120.7K | -4% | -$53.2K |
| D | 2024-09-11 | 2024-09-10 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 125.7K | +4% | +$11.7K |
| D | 2024-08-13 | 2024-08-12 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $11.53 | -5,000 | 120.7K | -4% | -$57.6K |
| D | 2024-08-13 | 2024-08-12 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 125.7K | +4% | +$11.7K |
| D | 2024-07-12 | 2024-07-10 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 175.7K | +3% | +$11.7K |
| DM | 2024-07-12 | 2024-07-10+ | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $16.79 | -55.0K | 148.7K | -27% | -$923.4K |
| D | 2024-06-12 | 2024-06-10 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 175.7K | +3% | +$11.7K |
| DM | 2024-06-12 | 2024-06-10 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $17.65 | -5,000 | 170.7K | -3% | -$88.3K |
| DT | 2024-05-14 | 2024-05-13 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $13.22 | -5,000 | 170.7K | -3% | -$66.1K |
| DT | 2024-05-14 | 2024-05-13 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 175.7K | +3% | +$11.7K |
| DT | 2024-01-09 | 2024-01-05 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +43.8K | 170.7K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations